restrictive oxygen supply
PreclinicalSmall molecule
restrictive oxygen supply is one of 4 small molecule programs targeting Thoracic Surgery. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Thoracic Surgery
#DrugCompanyPhaseTrials
1Dexmedetomidine Hydrochloride
PfizerPreclinical
S-Ketamine
PPeking University First Hospital
Preclinical
Vasoconstrictor Agents
UUniversity Hospitals Cleveland Medical Center
Preclinical
restrictive oxygen supply
MMedical University Innsbruck
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for restrictive oxygen supply. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMedical University Innsbruck